Prof. Dr. Sibylle Loibl is Chair of the German Breast Group and the Chief Executive Officer of the GBG Forschungs GmbH.

Prof. Dr. Loibl is an associate professor of obstetrics and gynaecology at the Goethe University of Frankfurt. She gained a doctorate at the Ruprecht Karl University of Heidelberg and trained as a consultant in gynaecology and obstetrics at the women’s clinics of the university hospitals in Heidelberg and Frankfurt am Main. She devotes most of her time to clinical research within the German Breast Group and clinical work at the Centre for Haematology and Oncology, Bethanien in Frankfurt.

Prof. Dr. Loibl has gained international renommée for her research in neoadjuvant breast cancer, breast cancer during pregnancy and breast cancer in young women. She established the Translational Research Group within the German Breast Group and has headed numerous research projects. In addition, Prof. Dr. Loibl has been involved in conducting and managing a significant number of national and international, practice-changing clinical trials.

Prof. Dr. Loibl is author of more than 400 original and peer-reviewed articles and scientific papers; she has written numerous books and book chapters. She is an active member of many important national and international organizations, such as ASCO, ESMO, DKG and the AGO. She is involved in national and international guidelines for breast cancer, amongst them those for ESMO and ASCO. She was the first Co-Chair of the ESMO Breast Conference in Berlin and is an active faculty member of many international (ASCO, ESMO, SABCS) conferences.